合丰集团(02320.HK)上半年净利润下降91.5%至172万港元
格隆汇8月29日丨合丰集团(02320.HK)发布中期业绩,截至2019年6月30日止6个月,公司实现收入5.969亿港元,同比下降6.6%;毛利7027.8万港元,同比下降23.4%;公司拥有人应占利润172万港元,同比下降91.5%;基本每股收益0.21 港仙;不派中期股息。
2019年上半年集团的收益比2018年上半年的收益下降了6.6%,主因是集团平均卖价下降及人民币汇率跌幅较大,纵使总销量有所上升也未能抵销价格及汇率的跌幅。上游箱板纸及下游瓦楞包装业务分别占总收益49.6%及50.4%。上半年的上游收益及下游收益与去年同期相比,分别上升63.2%及 下跌34.3%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.